Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2021 Cell & Gene Therapy Report
2021 Monoclonal Antibody & Recombinant Protein Market Report
2022 Sterile Drug Market Report
2022 API Market Report
2022 OSD Market Report
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Content Filter
Choose a Topic
ADC
Agreement
Appointment
Big Data
Biologics
Biomanufacturing
Biosimilars
Business
Capacity Expansion
CDMO
Cell and Gene Therapy
Clinical Trials
Collaboration
Continuous Manufacturing
CRISPR
CRO
DNA
Drug Delivery
Drug Development
Drug Discovery
Engineering
Equipment
Excipients
Facility
Formulation
Generics
Healthcare
Immunotherapy
Innovation
Investment
Licensing
Logistics
Manufacturing
Market Expansion
Market Intelligence
Market Prediction
Oncology
Oral Solid Dosage
Orphan Drugs
Packaging
Parenterals
Patient Centric
Preclinical
Process Development
Regulatory
Research
Serialization
Stem Cells
Strategic Partnership
Supply Chain
Vaccine
Intermediates
×
Choose a Section
Features
News
Press Releases
Roundtable
In Conversation
Nice Consulting
Virtual Panel
Trends Trending
×
Choose an Issue
Issue Q3 2022
Issue Q2 2022
Issue Q1 2022
Issue Q4 2020
Issue Q3 2020
Issue Q2 2020
Issue Q1 2020
Issue Q4 2019
Issue Q3 2019
Issue Q2 2019
Issue Q1 2019
Issue Q4 2018
Issue Q3 2018
Issue Q2 2018
Issue Q1 2018
Issue Q4 2017
Issue Q3 2017
Issue Q2 2017
Issue Q1 2017
Issue Q4 2016
Issue Q3 2016
Issue Q2 2016
Issue Q1 2016
Issue Q4 2015
×
5692 Articles Available
1
238
Can't find what you're looking for? Try our
advanced search
.
Consulting
Supporting Drug Development – Increasing Probability of Success
PAO-03-23-CL-04
Strategic Partnership
Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications
PR-M03-23-06
Tumor Microenvironment
Harnessing the Power of the Tumor Microenvironment with First-in-Class Therapies
PAO-03-23-CL-01
Bone Regeneration
A Novel Technology Platform for Bone Regeneration and Cancer Treatment
PAO-03-23-CL-06
New Biomanufacturing Facility
Samsung Biologics Announces Construction of Plant 5 to Commence Bio Campus II Capacity Expansion
PR-M03-23-05
CDMO Leadership Award
Olon Has Been Selected as Champion in Five Categories of 2023 CDMO Leadership Awards
PR-M03-23-04
Point of Care
Helping Clinicians Make Better Decisions More Easily
PAO-03-23-CL-05
Biomanufacturing
On the Journey to a New Industry Standard for E. coli-based Protein Production
PAO-03-23-CL-03
Cloud-Based Platform
Charles River Launches Apollo™, an Industry-Leading, Secure, Cloud-Based Platform for Real-Time Toxicology Study Data
PR-M03-23-03
Viral Vector Manufacturing
Considerations in Viral Vector Analytical Development to Enable Smooth Transfer to Quality Control
PAO-02-23-CL-03
New R&D Center
Addition of New U.S. R&D Center is the Next Step in Asymchem’s Globalization Strategy
PAO-02-23-CL-07
mRNA Ultra-Cold Chain Management
Ultra-Cold Chain and Supply Chain Management Strategies for mRNA
PAO-02-23-CL-09
UN Global Compact
CDMO Joins United Nations Global Compact
PR-M03-23-02
CDMO Leadership Award
Hovione Receives the 2023 CDMO Leadership Award in All Six Categories and Is Champion in Compatibility and Expertise
PR-M03-23-01
Data-Driven Patient Matching
Accelerating Oncology Clinical Trials with Deep Digitalization of Patient Data
PAO-03-23-CL-02
Digital Twin Technology
The Powerful Potential of Digital Twin Technology to Improve Drug Discovery, Development, Manufacturing, and More
PAO-03-23-NI-02
FDA New Drug Approvals
Many First-in-Class Drugs Approved by FDA in 2022, but Overall Approval Numbers Down
PAO-03-23-NI-03
Interchangeable Biosimilars
The Opportunities and Challenges Posed by Biosimilar Interchangeability
PAO-03-23-NI-01
Scale-Up
Scale-Up Expertise to Support Your Biologics Life Cycle
PAO-02-23-CL-06
Kidney Disease
Ascelia Pharma Meets Major Milestone with Patient Enrollment Completion of Phase 3 Study for Orviglance, Novel MRI Contrast Agent for Patients with Kidney Impairment
PR-M02-23-04
T Cell Expansion Platform
Terumo Blood and Cell Technologies Presents First Quantum® Flex Data for Multiple Size Bioreactors Showing Rapid T Cell Expansion to Numbers Equivalent of a Therapeutic Dose
PR-M02-23-03
New CDMO Facility
Leveraging a State-of-the-Art CDMO Facility to Advance Healthcare
PAO-02-23-PATV-04
Academic Research
Olon and The Chemistry Department of Politecnico University Launch a Research Project on Polymorphism and Characterization of API Solid State
PR-M02-23-02
Biopharma Facility Design
Growing a Global Presence with a Continued Focus on Life Sciences Facilities
PAO-02-23-PATV-03
1
238
»